THIS IS AN OPEN-LABEL, MULTI-CENTER, EXTENSION STUDY DESIGNED TO EVALUATE THE LONGER TERM SAFETY, TOLERABILITY AND EFFECTIVENESS OF LURASIDONE, FLEXIBLY DOSED, ADJUNCTIVE TO LITHIUM OR DIVALPROEX FOR THE TREATMENT OF SUBJECTS WITH BIPOLAR I DISORDER WHO HAVE PARTICIPATED IN STUDY D1050296: